Bank-Of-New-York-Mellon

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-29
Total Holdings
20,557
Total Value
248488795961
Accession Number
0001390777-25-000071
Form Type
13F-HR
Manager Name
Bank-Of-New-York-Mellon
Data Enrichment
92% identified
18,855 identified1,702 unidentified

Holdings

20,557 positions • $248.5B total value
Manager:
Search and click to pin securities to the top
Page 201 of 205
TENARIS SA
Shares:—
Value:$57.9K
% of Portfolio:0.0% ($57.9K/$248.5B)
Generation Bio Co.
Shares:—
Value:$56.6K
% of Portfolio:0.0% ($56.6K/$248.5B)
Southland Holdings, Inc.
Shares:—
Value:$56.3K
% of Portfolio:0.0% ($56.3K/$248.5B)
Acrivon Therapeutics, Inc.
Shares:—
Value:$56.1K
% of Portfolio:0.0% ($56.1K/$248.5B)
LanzaTech Global, Inc.
Shares:—
Value:$55.9K
% of Portfolio:0.0% ($55.9K/$248.5B)
ALX ONCOLOGY HOLDINGS INC
Shares:—
Value:$55.6K
% of Portfolio:0.0% ($55.6K/$248.5B)
Opera Ltd
Shares:—
Value:$54.1K
% of Portfolio:0.0% ($54.1K/$248.5B)
46428R107
Shares:—
Value:$53.7K
% of Portfolio:0.0% ($53.7K/$248.5B)
Drilling Tools International Corp
Shares:—
Value:$53.4K
% of Portfolio:0.0% ($53.4K/$248.5B)
Camp4 Therapeutics Corp
Shares:—
Value:$52.5K
% of Portfolio:0.0% ($52.5K/$248.5B)
Ovid Therapeutics Inc.
Shares:—
Value:$51.7K
% of Portfolio:0.0% ($51.7K/$248.5B)
IGM Biosciences, Inc.
Shares:—
Value:$50.7K
% of Portfolio:0.0% ($50.7K/$248.5B)
Century Therapeutics, Inc.
Shares:—
Value:$50.2K
% of Portfolio:0.0% ($50.2K/$248.5B)
PepGen Inc.
Shares:—
Value:$47.0K
% of Portfolio:0.0% ($47.0K/$248.5B)
FibroBiologics, Inc.
Shares:—
Value:$46.3K
% of Portfolio:0.0% ($46.3K/$248.5B)
Airship AI Holdings, Inc.
Shares:—
Value:$46.3K
% of Portfolio:0.0% ($46.3K/$248.5B)
Butterfly Network, Inc.
Shares:—
Value:$46.0K
% of Portfolio:0.0% ($46.0K/$248.5B)
BGSF, INC.
Shares:—
Value:$46.0K
% of Portfolio:0.0% ($46.0K/$248.5B)
Atour Lifestyle Holdings Ltd
Shares:—
Value:$43.6K
% of Portfolio:0.0% ($43.6K/$248.5B)
Co-Diagnostics, Inc.
Shares:—
Value:$42.4K
% of Portfolio:0.0% ($42.4K/$248.5B)